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Introduction

Results
Total Patients Scheduled

•

Cardiovascular disease (CVD) is the
leading cause of death in the US

•

The project was implemented in a primary
care clinic in rural East Tennessee

•

Annual United States (US) cost $316 billion

•

The clinic consisted of 3 clinics with 2 Nurse
Practitioners (NP) and 1 Physicians
Assistant (PA)

•

Expected to triple by 2030

•

Tennessee is 6th highest state in the US for
CVD deaths

•

Primary care plays a vital role in assessing
for CVD risk

•

Risk enhancing factors increase an
individual’s risk to develop CVD and must
be considered when assessing a patient’s
risk

•

•

One tool for assessing an individual’s risk is
the ASCVD Risk Estimator Plus by the
American College of Cardiology and
American Heart Association

•

Charts were accessed to gather applicable
data needed for calculation

•

ASCVD risk scores were calculated through
the free online website for public use

At the chosen clinical site, there is
not a standardized or streamlined
process currently for determining a
patient’s CVD risk which is
necessary because cardiovascular
disease can only be determined
through invasive procedures. As a
result, it is unclear if providers are
adequately assessing a patient’s
risk for developing cardiovascular
disease in order to implement
primary prevention treatments to
delay or prevent the onset of CVD.

Criteria
Excluded
Patients
142
30%

By completing ASCVD risk scores,
providers may initiate treatment in a moretimely and streamlined manner

•

Findings suggest that without a streamlined
process, patients may not be adequately
treated based on their risk

•

Lifestyle modifications for CVD prevention is
highly favorable as it has little to no risks
involved and is indicated treatment in every
risk category

•

ASCVD risk scores still need further
adjustment to more accurately assess an
individual’s risk in order to be used as
stand-alone decision-making tools

•

Until further adjustment occurs, ASCVD risk
scores should be used to guide decision
making rather than as stand-alone decision
making

•

ASCVD risk scores should be done in
primary care settings on applicable patients
according to guidelines
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Project Evaluation

20
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•

Chart reviews occurred at 1-month and 3month intervals post FLV date to evaluate if
an intervention was completed by the
patient’s provider
•
•

Implement ASCVD risk scoring into
standardized practice for all applicable
patients

Did the patient have intervention
completed within 1 month of ASCVD
risk calculation?
What interventions were
completed?

•

Did the patient have an intervention
that was completed after 1 month
but before 3 months post ASCVD
risk calculation?

•

•

Identify patients who have increased risk for
developing CVD

•

•

Through identification of risk, treatment can
be initiated sooner to delay or even prevent
CVD from occurring

•

Data was exported into an excel
sheet

•

Get ASCVD Risk Calculator integrated into
the EHR for easier and quicker access

•

Total ASCVD
Scores
Completed
190
41%

•

40

Project Goals
•

ASCVD risk scores were attached to the
patient’s lab results and forwarded to the
provider within the clinic’s EHR

Clinical problem:
•

Patients
Rescheduled/
No-Show
138
29%

ASCVD risk scores were calculated on all
applicable patients who presented to clinic
for fasting lab visit (FLV) between January
17 and February 28, 2022

•

•

Conclusions and Implications

Project Description

What interventions were
completed?
Did patient not have any
interventions completed within 3
months of ASCVD risk calculation?

Data was calculated to determine statistical
findings
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